RARE 营收历史(2016–2025)
Ultragenyx Pharmaceutical Inc. (RARE) 年度营收历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$673.0MFY2025 · FY2016 以来:$133,000 → $673.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $673.0M | +20.2% |
| FY2024 | $560.0M | +29.0% |
| FY2023 | $434.0M | +19.5% |
| FY2022 | $363.3M | +3.4% |
| FY2021 | $351.4M | +29.7% |
| FY2020 | $271.0M | +161.3% |
| FY2019 | $103.7M | +101.4% |
| FY2018 | $51.5M | +1871.5% |
| FY2017 | $2.6M | +1863.9% |
| FY2016 | $133,000 | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议